Trade Summary

5 days ago, Yea Christopher, serving as CHIEF DEVELOPMENT OFFICER at KalVista Pharmaceuticals, Inc. (KALV), sold 2,358 shares at $26.78 per share, for a total transaction value of $63,157.62. Following this transaction, Yea Christopher now holds 228,759 shares of KALV.

This sale represents a 1.02% decrease in Yea Christopher's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Friday, May 22, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, May 26, 2026 at 7:33 PM ET, 4 days after the trade was made.

KalVista Pharmaceuticals, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.